The Food and Drug Administration on Tuesday published safety guidelines requiring vaccine makers to monitor clinical trial participants for at least two months to rule out any side effects before the approval of any vaccine. The FDA’s rules were published over the objections of the White House, which was seeking to allow emergency use authorizations of vaccines ahead of the November 3 election.
FDA to Require Two Month Safety Review for Vaccines Before Emergency Use
HeadlineOct 07, 2020